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The Citrate Lyase (ACL) is the main cytosolic enzyme that converts the citrate exported
from mitochondria by the SLC25A1 carrier in Acetyl Coenzyme A (acetyl-CoA) and
oxaloacetate. Acetyl-CoA is a high-energy intermediate common to a large number
of metabolic processes including protein acetylation reactions. This renders ACL a
key regulator of histone acetylation levels and gene expression in diverse organisms
including humans. We have found that depletion of ATPCL, the Drosophila ortholog of
human ACL, reduced levels of Acetyl CoA but, unlike its human counterpart, does not
affect global histone acetylation and gene expression. Nevertheless, reduced ATPCL
levels caused evident, although moderate, mitotic chromosome breakage suggesting
that this enzyme plays a partial role in chromosome stability. These defects did
not increase upon X-ray irradiation, indicating that they are not dependent on an
impairment of DNA repair. Interestingly, depletion of ATPCL drastically increased the
frequency of chromosome breaks (CBs) associated to mutations in scheggia, which
encodes the ortholog of the mitochondrial citrate carrier SLC25A1 that is also required
for chromosome integrity and histone acetylation. Our results indicate that ATPCL
has a dispensable role in histone acetylation and prevents massive chromosome
fragmentation when citrate efflux is altered.
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INTRODUCTION
Acetyl coenzyme A (acetyl-CoA) is a high-energy intermediate common to a large number
of metabolic processes, including lipogenesis and cholesterogenesis that take place in different
intracellular compartments. Acetyl-CoA is also required for protein acetylation reactions, which
are important in post-translation modifications of proteins such as histones.
Acetyl coenzyme A may be synthesized in mitochondria and exported to the cytosol.
This transport is strictly dependent on the citrate-malate-pyruvate shuttle. For this process,
mitochondrial acetyl-CoA is first condensed with oxaloacetate by citrate synthase thus producing
citrate and free CoA. Citrate is then exported to the cytosol through the mitochondrial citrate
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carrier SLC25A1. Here, acetyl-CoA generation is mediated by
the activity of the ATP-cytrate lyase (ACL), which catalyzes
the ATP-dependent cleavage of mitochondrial-derived citrate
into oxaloacetate and acetyl-CoA (Chypre et al., 2012). Finally,
the malate dehydrogenase 1, NAD (soluble; MDH1) converts
cytosolic oxaloacetate by catalyzing the NADH-dependent
synthesis of malate, which is transported back to the mitochondria
through SLC25A10, an inorganic phosphate/dicarboxylate
antiporter. Given its key role in the production of cytosolic
acetyl-CoA, it is not surprising that ACL serves several and
crucial functions in mammal metabolism (Wellen et al., 2009;
Lee et al., 2014, 2015; Das et al., 2015; Covarrubias et al., 2016;
Deb et al., 2017; Chen et al., 2018; White et al., 2018).
Although ACL resides mainly in the endoplasmic reticulum
in mammalian cells (Chypre et al., 2012), it can be found
also in the nucleus (Wellen et al., 2009). Here, as citrate can
diffuse through the nuclear membrane, it produces acetyl-CoA,
which is directly required to promote histone acetylation and
regulate gene expression in response to growth factor stimulation
and during differentiation (Wellen et al., 2009). ACL has been
recently shown to be phosphorylated at S455 downstream of
ataxia telangiectasia mutated (ATM) and AKT following DNA
damage (Sivanand et al., 2017). This phosphorylation is necessary
for BRCA1 recruitment and DNA repair by homologous
recombination and identifies ACL as a molecular player in the
DNA damage response.
A large amount of evidence indicate that ACL is upregulated
or activated in several types of cancer (Zaidi et al., 2012b). Cancer
cells rely on glucose as major carbon source for de novo fatty acid
synthesis. Glycolysis generates citrate by tricarboxylic acid (TCA)
cycle, the citrate is preferentially exported from mitochondria to
cytosol and then cleaved by ACL to produce cytosolic acetyl-
CoA, the building block for de novo lipid synthesis. Thus, by
coupling energy metabolism with fatty acids synthesis, ACL plays
a critical role in supporting cancer cell growth. It is not therefore
unexpected that inhibition of ACL dramatically suppresses tumor
cell proliferation (Zaidi et al., 2012a; Migita et al., 2013, 2014; Gao
et al., 2014; Lee et al., 2015; Wang et al., 2017; Granchi, 2018).
Here we show that depletion of ATPCL, the Drosophila
ortholog of human ACL, leads to a moderate frequency of
chromosome breaks (CBs) indicating that this enzyme is partially
required for chromosome stability in mitotic cells. Interestingly,
the number of CBs is substantially enhanced when the export of
citrate from mitochondria is inhibited suggesting that the ATPCL
role on chromosome integrity is essential when cytosolic citrate
is limited. We also show that ATPCL mutants exhibit decreased
levels of Acetyl CoA but this reduction does not affect global
histone acetylation and gene expression. This indicates that,
unlike its human counterpart, the role of ATPCL in Drosophila
histone acetylation could be redundant.
RESULTS
The Drosophila ATP Cytrate Lyase
We previously demonstrated that perturbation in the citrate
metabolism leads to genome instability in both Drosophila and
human cells as consequence of reduced Acetyl-CoA production
(Morciano et al., 2009). To further understand the contribution
of the acetyl-CoA metabolism to the maintenance of genome
stability, we focused our characterization on the ATP Cytrate
Lyase. This enzyme cleaves TCA-derived citrate in oxaloacetate
OAA (that in turn is converted into malate in order to re-
entry in the mitochondria) and catalyzes the formation of
acetyl-CoA in the presence of ATP. In Drosophila, the citrate
lyase-encoding gene (CG8322, FBgn0020236) maps on 52D9-
11 chromosome 2 region and consists of 10 exons (including
the 5′ and 3′ UTR sequences) that, according to the FlyBase
annotation, specifies four potential transcripts (namely ATPCL-
RD, -RE, -RG, and -RF) that retain all exons albeit with few
differences (Supplementary Text). Our RT-PCR and sequencing
analysis confirmed the presence of these different transcripts
(Supplementary Text). Moreover, qPCR revealed that ATPCL-
RD and RF are poorly expressed with respect to ATPCL-RD/RE
suggesting that ATPCL-PD/PE is the most representative ATPCL
gene product (Figure 1B). Despite the differences in the exons
6, all transcripts encode almost identical ATPCL proteins that
overall shares 70% of identity with the human counterpart,
hACL. It is therefore conceivable that ATPCL is also functionally
analogous to hACL (see also below).
FIGURE 1 | Molecular analysis of ATPCL mutations. (A) An analysis of the
published DNA sequence reveals that ATPCL-encoding gene CG8322
specifies four potential transcripts RD, RE, RF and RG. The black triangles
indicate the position of the P{PZ}ATPCL01466 and P{wHy}ATPCLDG23402
insertions in the ATPCL locus referred as ATPCL01466 and ATPCLDG23402,
respectively. Green boxes: encoding exons; gray boxes: UTR-containing
exons; horizontal black lines: introns. (B) Western blot of third instar larvae
brain extracts from control (OR/R) and ATPCL mutants. The anti-ATPCL
antibody recognizes a ∼130 KDa band which is significantly reduced in all
ATPCL mutant combinations. Df (2R) is the Df(2R)Exel7138 deficiency that
removes ATPCL. Tubulin is used as a loading control. The bottom figure
illustrates the quantification analysis of ATPCL levels, which has been based
on band intensities of three independent WBs (biological replicates). Bars
indicate standard deviation. (C) Reduced levels of Acetyl CoA in ATPCL
mutants. Columns indicate the percentage of Acetyl-CoA quantification
(pmol/ml) in both ATPCLDG23402 and ATPCLDG23402 hemizygotes with respect
to OR/R (control; ∗p < 0.01, Student t-test). Bars show SD.
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We obtained from the Bloomington stock center two putative
P-element induced ATPCL mutant alleles, ATPCL01466 and
ATPCLDG23042. Our PCR analysis confirmed that ATPCL01466
and ATPCLDG23042 are located within the 5′ UTR of the gene at
position −340 and −1167 upstream of the translation initiation
site, respectively (Figure 1A). ATPCL01466 homozygotes and
ATPCL01466/ Df(2R)Exel7138 hemizygotes (Df(2R)Exel7138 is a
deficiency in the 52D1-52D12 polytene region that removes
ATPCL) were late lethal while either ATPCLDG23042 homozygotes
and hemizygotes displayed semi-lethality. By mobilizing the
ATPCLDG23042 P-element, we generated an additional lethal
ATPCL mutant allele (17), which potentially bears partial
deletions of the gene and severely affected ATPCL expression
(see below). This suggests that loss of function of ATPCL might
prevent development as it occurs also for ACL knock-out mice
(Beigneux et al., 2004). Finally, the expression of a wild type
UAS ATPCL transgene under the control of a TubGal4 promoter
in ATPCLDG23042 or ATPCL01466 mutant background rescued
the late lethality and CBs (see section “Materials and Methods”)
confirming that both phenotypes are due to lesions in the
ATPCL gene.
We have generated a guinea pig anti ATPCL polyclonal
antibody that in Western blotting (WB) analysis on larval brain
extracts detected a band of expected size (∼130 KDa), which
decreased in ATPCL mutants (Figure 1B). ATPCL01466/ATPCL17
trans heterozygotes yielded to the strongest reduction (∼80%)
of expression of the ATPCL protein indicating that this
mutant allele combination represents the most severe condition
(Figure 1B). Immunofluorescence (IF) on larval neuroblasts with
the same anti-ATPCL antibody revealed that ATPCL exhibits
a punctuate localization pattern both in the cytoplasm and
nucleus, which is absent from mutant cells (Supplementary
Figure 2). However, as cells enter mitosis, ATPCL is excluded
from the portion of nucleus containing chromatin and is
retained predominantly in the cytoplasm. This pattern is clearly
visible in either metaphase or ana-telophase in which ATPCL is
enriched in the entire cell except the portion surrounding the
dividing chromosomes (Supplementary Figure 2). Thus, like its
human counterpart (Wellen et al., 2009), ATPCL localizes to the
cytoplasm and the nucleus in interphase. Moreover, the nuclear
localization changes during mitosis.
Finally, our fluorometric analysis revealed that Acetyl-CoA
levels are ∼40% reduced in ATPCL mutants with respect
to wild-type (1.30 pm/µl) indicating that, similarly to its
mammalian counterpart, ATPCL is required for Acetyl-CoA
synthesis (Figure 1C).
The ATPCL Role in Mitosis
In the citrate-dependent Acetyl CoA biosynthesis, ACL works
downstream the citrate mitochondria carrier SLC25A1 (see
section “Introduction”). As SLC25A1 and Scheggia (Sea, the
SLC25A1 fly ortholog) are required for chromosome integrity
in mammalian and Drosophila cells, respectively (Morciano
et al., 2009), we asked if also ATPCL was involved in the same
process. The analysis of DAPI-stained colchicine-treated mitotic
neuroblasts from the different ATPCL mutant larval brains
revealed that ATPCL mutants exhibited a moderate, although
statistically significant, number of CBs (2.5–4.5%; Total Cells
= 250; Figure 2). Moreover 2 Gy X-ray exposure did not
enhance the number of CBs of ATPCL mutants indicating that
they do not result from defective DNA repair (Figure 2B).
However, WB and IF analyses using anti-acetylated H4 and
H3 histones indicated that the overall histone acetylation in all
ATPCL mutants was not significantly affected (Supplementary
Figure 3). Although it cannot be ruled out the possibility that
reduction of histone acetylation occurs at damaged sites, our
FIGURE 2 | Depletion of ATPCL yields to chromosome breaks (CBs). (A) DAPI-stained female metaphases from larval neuroblasts of control (Oregon R, a), ATPCL
mutants (b,c) and ATPCL, sea double mutants (d). Numbers in (a) indicate chromosomes X, 2, 3, and 4 of a normal female caryotype. White arrows and
arrowheads indicated chromatid and CBs, respectively. Bar: 5 µm. (B) Frequency of CBs in ATPCL mutants. All ATPCL mutants exhibit a moderated (although
statistically significant) frequency of CBs, which are almost absent in control cells (∗p < 0.05, Student t-test). CBs frequency is not influenced by a 2 Gy X-ray
irradiation. Note that the frequency of CBs in ATPCL; sea double mutants is higher than the sum of CB frequencies observed in either ATPCL or sea single mutants
(indicated by the dotted line) suggesting a synergistic effect. ∼200 cells (4 slides) for mutant combinations and ∼500 (5 slides) for Oregon R (control) were analyzed.
See text for further details. Bars refer to SD.
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observations suggest that chromosome defects are not dependent
on a general reduction of histone acetylation. We then verified
whether ATPCL and scheggia (sea) could genetically interact. The
cytological analysis of mitotic metaphases from late lethal ATPCL
sea double mutants revealed that CBs frequency is synergistically
increased (∼46%; Total Cells = 180) with respect to the sum of
break frequencies of both ATPCL (4.5%) and sea ∼25%; (Total
Cells = 200; Figure 2B). This indicates that ATPCL prevents
genome instability when certain intracellular metabolites
(i.e., citrate) are limited.
ATPCL Is Not Required for
Global Gene Transcription
We next asked whether loss of ATPCL could at least
influence the expression of potential ATPCL-responsive mitotic
genes. Thus we extracted RNA from either wild-type or
ATPCL mutant brains, labeled, and hybridized to CDMC 14K
Drosophila arrays (Canadian Drosophila Microarray Center,
Toronto, Canada). Surprisingly, only ∼5% (772) of the genes
significantly changed their transcriptional profile indicating
that loss of ATPCL only marginally affected global gene
transcription. Of these, approximately 23% (182) were > 2-fold
either down- or up-regulated (Supplementary Table S1). Gene
ontology (GO) revealed a clear functional bias toward brain
development and behavior gene categories indicating a potential
requirement of ATPCL in the regulation of nervous system genes
(Supplementary Figure 4). However, based on these results, we
cannot discriminate whether the change in gene expression is a
direct consequence of the loss of histone acetylation rather than
that of secondary responses to metabolic alterations induced by
loss of acetyl-CoA. Yet, as microarrays were probed with larval
brain RNA we cannot exclude that the observed trends on brain
development might reflect a tissue-specific function of ATPCL in
gene regulation.
DISCUSSION
Here we have molecularly characterized for the first time
ATPCL that encodes the Drosophila ortholog of human ATP
citrate lyase. We have shown that, consistently with previous
findings in other organisms including mammals, mutations in
the ATPCL reduce cytosolic acetyl-CoA confirming that ACL
has an evolutionarily conserved role in Acetyl-CoA biosynthesis.
However, despite Drosophila ATPCL mutants exhibit an evident,
although moderate, mitotic chromosome breakage phenotype,
depletion of ATPCL, unlike human cells, has not a general
impact on histone acetylation in flies suggesting that it role in
histone acetylation is either partially redundant in Drosophila
or compensated by alternative pathways (i.e., from acetate by
acyl-CoA synthetases). However, it cannot be ruled out the
possibility that ATPCL could be required for the acetylation of
either nuclear or cytoplasmic factors, instead of histones, that
in turn are required for chromosome integrity. Alternatively,
as ATPCL plays a direct role in the homeostasis of lipids,
whose modifications (i.e., peroxidation) are also required to
modulate DNA repair (Tudek et al., 2017), it is possible that
ATPCL mutants defects on chromosome integrity could arise
as a consequence of protein acetylation-independent activity.
Proteomic studies will be fundamental to verify these hypotheses.
We have previously demonstrated that mutations in the
mitochondrial citrate carrier Sea/SLC25A1, led to frequent CBs
in Drosophila mitotic cells (Morciano et al., 2009). The finding
that perturbation of ATPCL, a key component of the pathway
that from citrate generates Acetyl-CoA, affected mitosis only
marginally was therefore unexpected. Moreover, our WB analysis
revealed that, unlike Sea/SLC25A1, ATPCL is not required
for the acetylation of histones, which could be required for
chromosome integrity. However, this does not exclude that a
decreased acetyl-CoA concentration could affect the local kinetics
of HAT-dependent histone acetylation at selected genomic loci
and/or damaged sites thus leading to specific changes in histone
acetylation. Finally, our transcriptomic analysis that indicates
that depletion of ATPCL has a modest modulatory effect on
transcription, limited to few classes of genes (although with a
bias toward brain development functions), further sustains the
view that loss of ATPCL has a minimal effect on bulk chromatin
histone acetylation.
The different effect of loss of Sea and ATPCL on Drosophila
chromosome integrity is intriguing. This is not due to the
molecular nature of mutant alleles of either sea or ATPCL,
which are almost genetically null and exhibited a strong
reduction of corresponding transcripts. It is conceivable that
citrate deprivation in sea mutants causes much greater effects
than reduction of Acetyl-CoA in ATPCL mutants. Indeed,
citrate may play different tissue-specific metabolic roles and
function as a general chelator of physiologically important
cations. Thus its deprivation in the cytosol may compromise
several intracellular pathways. Citrate reduction as consequence
of inhibition of Sea/SLC25A1 transport activity might also
inhibit ATPCL activity and/or expression thus exacerbating the
ATPCL mutant phenotype. It has been recently demonstrated
that in Drosophila citrate may indeed regulate a feedback
mechanism that coordinates intracellular metabolism with
glycolysis and TCA cycle (Li et al., 2018). It could be
important to understand whether this metabolic feedback loop
may also involve ATPCL. Our findings that ATPCL depletion
in sea mutants yields to a synergic CBs phenotype suggest
that ATPCL prevents chromosome fragmentation when citrate
metabolism is impaired.
The mild phenotype associated with loss of ATPCL in
Drosophila does not preclude the possibility that also the
overexpression of ATPCL may impact Drosophila somatic
cell proliferation. Overexpression of the human ortholog ACL
supports cancer growth by fueling the glucose-dependent de novo
lipogenesis. Whether a similar histone-acetylation independent
effect takes place also in Drosophila will be an interesting issue to
address in the future.
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